BR112023019392A2 - Radiofarmacêuticos para arts diferentes - Google Patents
Radiofarmacêuticos para arts diferentesInfo
- Publication number
- BR112023019392A2 BR112023019392A2 BR112023019392A BR112023019392A BR112023019392A2 BR 112023019392 A2 BR112023019392 A2 BR 112023019392A2 BR 112023019392 A BR112023019392 A BR 112023019392A BR 112023019392 A BR112023019392 A BR 112023019392A BR 112023019392 A2 BR112023019392 A2 BR 112023019392A2
- Authority
- BR
- Brazil
- Prior art keywords
- application
- pharmaceutics
- radio
- different
- radionuclide
- Prior art date
Links
- 238000000034 method Methods 0.000 abstract 3
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 229940127557 pharmaceutical product Drugs 0.000 abstract 1
- 229940121896 radiopharmaceutical Drugs 0.000 abstract 1
- 239000012217 radiopharmaceutical Substances 0.000 abstract 1
- 230000002799 radiopharmaceutical effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/121—Solutions, i.e. homogeneous liquid formulation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Optics & Photonics (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dispersion Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Abstract
radiofarmacêuticos para arts diferentes. a presente invenção refere-se a um método e a um aparelho para produzir produtos contendo radionuclídeos tendo substancialmente a atividade de radioatividade idêntica desejada em diferentes momentos de aplicação, em relação a um determinado tempo de calibração. em contraste com os procedimentos da técnica anterior, o método de acordo com a invenção permite assegurar uma composição consistente do produto farmacêutico marcado com radionuclídeos desejado em todos os momentos de aplicação dentro do prazo de validade através de um único processo de fabricação. com a presente invenção é possível, por exemplo, fornecer [n.c.a. lu-177]lu-dotatoc em cada dia útil da semana com atividade constante no respectivo momento de aplicação em uma única etapa de fabricação.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102021109246.9A DE102021109246B3 (de) | 2021-04-13 | 2021-04-13 | Radiopharmaka zu unterschiedlichen ARTs |
| PCT/EP2022/057040 WO2022218640A1 (de) | 2021-04-13 | 2022-03-17 | RADIOPHARMAKA ZU UNTERSCHIEDLICHEN ARTs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112023019392A2 true BR112023019392A2 (pt) | 2023-11-07 |
Family
ID=81308217
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112023019392A BR112023019392A2 (pt) | 2021-04-13 | 2022-03-17 | Radiofarmacêuticos para arts diferentes |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP4323018A1 (pt) |
| JP (1) | JP2024515950A (pt) |
| CN (1) | CN117136078A (pt) |
| AU (1) | AU2022258486A1 (pt) |
| BR (1) | BR112023019392A2 (pt) |
| CA (1) | CA3213588A1 (pt) |
| DE (1) | DE102021109246B3 (pt) |
| IL (1) | IL307173A (pt) |
| WO (1) | WO2022218640A1 (pt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115433260A (zh) * | 2022-11-09 | 2022-12-06 | 南京硼高生物科技有限公司 | 一种靶向ALK融合蛋白的放射性多肽68Ga-DOTA-PG01及其制备方法与应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE271396T1 (de) | 2000-05-12 | 2004-08-15 | Univ Hospital | Prochelators von radiometall markierten molekülen |
| DE10040771A1 (de) * | 2000-08-21 | 2002-03-14 | Altmann Therapie Gmbh & Co Kg | Neue, 224Ra enthaltende, radiotherapeutisch wirksame Formulierungen und Verfahren zu ihrer Herstellung |
| DE102011051868B4 (de) | 2011-07-15 | 2013-02-21 | ITM Isotopen Technologien München AG | Verfahren zur Herstellung trägerfreier hochreiner 177Lu-Verbindungen sowie trägerfreie 177Lu-Verbindungen |
| HUE046302T2 (hu) | 2016-12-27 | 2020-02-28 | Itm Isotopen Tech Muenchen Ag | 68Ge/68Ga generátor |
| US10596278B2 (en) | 2018-07-25 | 2020-03-24 | Advanced Accelerator Applications (Italy) S.R.L. | Stable, concentrated radionuclide complex solutions |
-
2021
- 2021-04-13 DE DE102021109246.9A patent/DE102021109246B3/de active Active
-
2022
- 2022-03-17 CA CA3213588A patent/CA3213588A1/en active Pending
- 2022-03-17 IL IL307173A patent/IL307173A/en unknown
- 2022-03-17 AU AU2022258486A patent/AU2022258486A1/en active Pending
- 2022-03-17 JP JP2023563179A patent/JP2024515950A/ja active Pending
- 2022-03-17 EP EP22716372.2A patent/EP4323018A1/de active Pending
- 2022-03-17 WO PCT/EP2022/057040 patent/WO2022218640A1/de active Application Filing
- 2022-03-17 BR BR112023019392A patent/BR112023019392A2/pt unknown
- 2022-03-17 CN CN202280025012.2A patent/CN117136078A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4323018A1 (de) | 2024-02-21 |
| DE102021109246B3 (de) | 2022-06-09 |
| AU2022258486A1 (en) | 2023-11-09 |
| CN117136078A (zh) | 2023-11-28 |
| JP2024515950A (ja) | 2024-04-11 |
| CA3213588A1 (en) | 2022-10-20 |
| IL307173A (en) | 2023-11-01 |
| WO2022218640A1 (de) | 2022-10-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mansouri et al. | Deep brain stimulation for Parkinson’s disease: meta-analysis of results of randomized trials at varying lengths of follow-up | |
| Zinkhan et al. | Agreement of different methods for assessing sleep characteristics: a comparison of two actigraphs, wrist and hip placement, and self-report with polysomnography | |
| BR112023019392A2 (pt) | Radiofarmacêuticos para arts diferentes | |
| Sahlem et al. | Oscillating square wave transcranial direct current stimulation (tDCS) delivered during slow wave sleep does not improve declarative memory more than sham: a randomized sham controlled crossover study | |
| BRPI0513050A (pt) | derivado de perimidina ou um sal, solvato ou pró-droga farmaceuticamente aceitável do mesmo, processo para a preparação do mesmo, composição farmacêutica, uso de um derivado de pirimidina ou de um sal, solvato ou pró-droga farmaceuticamente aceitável do mesmo, e, método para produzir um efeito anti-proliferativo em um animal de sangue quente | |
| Hill et al. | NT2 derived neuronal and astrocytic network signalling | |
| BRPI0606326A2 (pt) | n-aminometileno sulfonamidas substituìdas, produção e uso das mesmas como medicamentos | |
| Deuschl et al. | Comparing two randomized deep brain stimulation trials for Parkinson’s disease | |
| AR109224A2 (es) | Formas de sales cristalinas de un compuesto 8-azabiciclo[3,2,1]octano, composición farmacéutica que las comprende, procesos para prepararlas, compuesto intermediario de síntesis relacionado y su uso para la fabricación de un medicamento | |
| BR0315082A (pt) | Preparação sólida | |
| BR112023018237A2 (pt) | Fenalquilaminas e métodos para fabricação e uso das mesmas | |
| BR112017011315A2 (pt) | ?cerâmica de vidro cristalizado de alta resistência que compreende wollastonita, hidroxiapatita e akermanita?. | |
| Panepinto et al. | Keeping alcoholics in treatment; effective follow-through procedures | |
| ATE338763T1 (de) | Progesteronrezeptormodulatoren mit erhöhter antigonadotroper aktivität für die weibliche fertilitätskontrolle und hormonersatztherapie | |
| Lach et al. | Effect of cellular mass on chondrogenic differentiation during embryoid body formation | |
| Pek et al. | Health-related quality of life in children with cancer undergoing treatment: A first look at the Singapore experience | |
| Al Naqbi et al. | In vitro assessment of cytotoxicity and estrogenicity of Vivera® retainers | |
| AR054048A1 (es) | Compuesto de 2- amino-4-oxo-1,3-tiazol-5- substituido, composicion farmaceutica que lo comprende, proceso para prepararla y uso del mismo para preparar un medicamento | |
| Stengel | The changing landscape of product development and randomized trials | |
| NO20090252L (no) | Camptotecinderivater med antitumoraktivitet | |
| Chen et al. | Three-dimensional evaluation of condylar morphology remodeling after orthognathic surgery in mandibular retrognathism by cone-beam computed tomography | |
| Oda et al. | Clarifying the mechanism of effect of the Bionator for treatment of maxillary protrusion: A percentile growth study. | |
| Suchánková et al. | Therapeutic drug monitoring of beta-lactam antibiotics | |
| Chaban et al. | Safety and efficacy of the Deprilium® complex in reducing subclinical symptoms of depression in patients with chronic non-communicable diseases: a double-blind, randomized controlled trial| Український Медичний Часопис | |
| Scutariu et al. | METHODS OF INTEGRATING AESTHETIC REHABILITATION INTO THE TREATMENT PLAN OF ELDERLY PATIENTS. |